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Activity of interferon a, interleukin 6 and insulin in the regulation of
differentiation in A549 alveolar carcinoma cells
C McCormick, RI Freshney and V Speirs*
CRC Department ofMedical Oncology, University ofGlasgow, Alexander Stone Building, Garseube Estate, Switchback Road,
Bearsden, Glasgow G61 2HA, UK.
S_umary The differentiation of A549. a human tumour cell line from type II pneumocytes. can be induced
by a crude fibroblast-derived factor (FDF) isolated from the conditioned medium of glucocorticoid-treated
lung fibroblasts. In the present report. we have used alkaline phosphatase as a differentiation marker to
investigate the activity of a number of growth factors as potential candidates for this paracrine activity. This
showed that insulin. interleukin 6 (IL-6), and interferon m (IFN-a) could simulate the activity of conditioned
medium. Their effects were dexamethasone (DX) dependent, additive and reversible with a half-life of I week.
Transforming growth factor c and P. IL-Ir and epidermal growth factor, were all inhibitory, and inhibition
was opposed, partially or completely. by DX. The most potent inducer was IL-6, but as DX was shown to
decrease the concentration of IL-6 in lung fibroblast-conditioned medium it seems an unlikely candidate for
FDF. Unlike FDF, all of the positive-acting factors were shown to induce plasminogen activator. FDF has
also been shown to be active in the absence of DX. This suggests that differentiation-inducing activity may be
present in several paracrine factors, but that so far a candidate for FDF has not been identified.
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Induction of differentiation has been considered as a possible
component of therapy for cancer (Waxman et al.. 1988). but
the agents found to be most effective in vitro, such as di-
methylsulphoxide (DMSO) and hexamethylene bisacetimide
(HMBA), are often not effective in vivo or are limited by
toxicity (Egonrn et al., 1987; Ward et al., 1991). Clinical
success with retinoids (Meyskens, 1993) and the different-
iation-inducing effect of glucocorticoids (McLean et al., 1986)
and cytokines (Wuarin et al., 1991) in vitro suggest that
physiological regulation may be feasible, at least for a com-
ponent of the tumour cell population, and applicable in
combination with cytotoxic chemotherapy (Huang and Wax-
man, 1994).
Cell interaction is clearly established as a major component
in the regulation of differentiation in embryonic development
(Jessell and Melton, 1992), and observations on skin
(Fusenig, 1992), prostate (Cunha et al., 1983), uterus (Cunha
and Young, 1992) and breast (Adams et al.. 1991) suggest
that cell interaction continues to be important in adult
development and homeostasis. Frequently, the status of one
or both interacting cell populations is governed by systemic
hormone activity (Cunha et al., 1983; Cunha and Young,
1992). The maturation of lung alveoli at parturition illus-
trates very effectively, both the need for cell interaction and
the indirect hormonal regulation of the differentiated func-
tion of lung epithelium. The onset of pulmonary surfactant
(PS) synthesis at birth is regulated by glucocorticoid via its
action on lung fibroblasts, causing them to secrete fibro-
cyte-pneumocyte factor (FPF), which stimulates PS syn-
thesis in the type II pneumocyte (Smith and Fletcher.
1979).
In a previous report (Speirs et al., 1991), we showed that
the A549 cell, a tumour of human type II pneumocytes
(Lieber et al., 1976), responds to a factor, or factors, released
by normal fetal lung fibroblasts treated with 0.25;LM dexa-
methasone (DX; a synthetic analogue of hydrocortisone), by
inducing synthesis of PS. This was accompanied by a decline
in the activity of plasminogen activator, a reduction in soft
agar cloning and reduced growth as xenografts in nude mice,
suggesting a shift to a more differentiated and less malignant
phenotype.
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Edelson et al. (1988) showed that maturation of the type II
pneumocyte is accompanied by an increase in alkaline phos-
phatase (AP) activity, and this marker has been used in the
present study to demonstrate that conditioned medium from
DX-treated fibroblasts (DXCM) also induces AP activity in
A549 cells. DX is active on A549 cells alone, but its activity
is greatly enhanced by conditioned medium from DX-treated
lung fibroblasts. However, while this conditioned medium is
active for the induction of PS synthesis after DX had been
removed (Speirs et al., 1991), the continued presence of DX
is required for induction of AP activity. The precise role of
DX is as yet unclear.
The effects of a panel of growth factors have been com-
pared with those of conditioned medium using the alkaline
phosphatase assay. Growth factors were chosen partly
because of availability and partly because they have pre-
viously been demonstrated to have activity in other epithelial
systems, e.g. prostate and skin. IFN-a, IL-6 and insulin were
all found to be active in inducing alkaline phosphatase in
A549 cells. Their activities were additive and their combined
activity was greater than that of conditioned medium. While
all the growth factors, with the exception of basic fibroblast
growth factor (bFGF, FGF-2), required the presence of DX
for activity, a combination of IFN-x, IL-6 and insulin was
active without DX, although not as active as DXCM or
conditioned medium with DX added during induction
(CM + DX).
Materials and methods
Cell culture
A549 cells (Giard et al., 1972) were obtained from the
American Type Culture Collection (Rockville, MD, USA)
(CCL-185) and maintained in 50:50 Ham's FIO-DMEM
(LTI, Paisley, UK) supplemented with 10% fetal bovine
serum during routine maintenance, in a gas phase of 2%
carbon dioxide. MOG-LF113 (LF113) is a normal fetal
human lung fibroblast initiated in this laboratory, and was
maintained in the same medium, serum and gas phase.
MOG-BF cells were derived from reduction mammoplasty
human breast tissue by collagenase digestion (J Godden,
Medical Oncology, Glasgow, unpublished), SFs are skin
fibroblasts (obtained from T Flannigan and K Whaley,
University Department of Pathology, Western Infirmary,Glasgow, UK) and 9E cells are a clone of NIH3T3, pre-
viously designated ThyF and active in promoting prolifera-
tion in thyroid epithelium (Bond et al., 1992).
Conditioned mediwn
LF 113 cells were seeded at 2 x 10' cells ml-' (4 x 0I cm-2),
grown to confluence (-2 x I05 cellscm-2) and either chang-
ed to serum-free F10-DMEM immediately or grown for a
further 8 days in FIO-DMEM with 1% FBS and then
changed to serum-free FIO-DMEM for conditioning. Condi-
toning was carried out in serum-free F10-DMEM alone
(CM) or with 2.5 x 10-7 M DX added (DXCM). The cultures
were then maintained for 3 days, and the medium collected
and stored at -20-C until used. Before use it was centrifuged
at 2000g for 20 min and filtered through a 0.22pm GV filter
(Millipore). Filtered conditioned medium was diluted 50:50
in serum-free medium for use.
Conditioned medium collec from fibroblasts which had
been left in plateau for 8 days was found to be more active
than that from fibroblasts which had newly entered plateau,
and thus was used throughout.
Induction conditions
Induction of alkaline phosphatase was carried out in micro-
titration plates. A549 cells were seeded at 1 x IO' cells ml-'
(1.3 x I05 cells cm-) and grown for 3 days. Growth factor or
50% CM was added in the presence or absence of 2.5 x
10-7 M DX, or 50% DXCM was added, for a further 3 days.
The medium was then removed, the cells washed in phos-
phate-buffered saline (PBS), frozen and thawed three times in
the residue after the last PBS wash, and alkaine phosphatase
activity determined on the lysate.
Alkalinephosphatase assay
Alkaline phosphatase was assayed by Sigma Kit 104. Briefly,
p-nitrophenyl phosphate was added to the cell lysate in the
microtitration plate along with assay buffer at pH 10.5, in a
total volume of 100PI. The plate was incubated for 1 h at
3TC and then 100jl of 0.1 M sodium hydroxide was added
and the absorbance ofthe freep-nitrophenol detamined on a
BioRad enzyme-linked immunoasorbent assay (ELISA) plate
reader at 405nm. Cell numbers were determined in a re-
plicate plate, and the activity of alkalin phosphatase ex-
pressed as pmol of p-nitrophenol released per hour per 101
cels.
Plasminen activator
Plasminogen activator activity was masured by a chromo-
genic assay which cleaves p-nitroanilie from a conjugated
peptide S-2251 (Kabi-Vitrum) in the presnce of 0.15 mg
ml-l poly-D-lysine (Whur et al., 1980). The yellow product
was read on an ELISA plate reader at 405 nm.
Growthfactors
Growth factors were obtained as indicated in Table I.
Bioassay ofIL-6
IL-6 was assayed by the method of Wadhwa et al. (1991).
Briefly, B9 myeloma cells were exposed to a series of dilu-
tions of standard IL-6, CM, DX, DXCM and CM + DX, in
the presence and absence ofanti-IL-6 antibody (NlBSC), and
the cell number determined 3 days later while the cells were
in exponential growth. The sensitivity of the assay was
5 pgml-' and the inter- and intra-assay coefficients of
variance were both <10%. There was no cross-reactivity
with IL-2, IL-3, IL-4, IL-5, tumour necrosis factor (TNF),
GM-CSF and IFN-'y.
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ReseIs
Effect ofDXandconditionedmediun on APactivity
The induction with DX alone tended to vary from one
experiment to another (1.5-fold to 5-fold; mean=2.5-fold,
s.e.m. =0.06-fold), and when the induction was carried out
in different DX concentrations it was found that 0.25gLM fell
close to the mid-point of inflection of the curve of activity vs
DX concentration (Figure 1) where minor fluctuations in
environmental conditions may have had the greatest effect on
AP induction. When CM and DXCM were compared with
DX alone, it was seen that DXCM was active at 50-100 nM
DX, whereas little or no effect was observed with DX alone.
CM + DX only showed acti'vity greater than DX alone at
higher DX concentrations (>0.1I M).
A549 cells were treated with medium from post-confluent
fibroblasts, conditioned in the presence (DXCM) or absence
Tabe I Growth factors, concentration range and supphers
Growthfactor Concentration range Suppler
EGF 1-OpgmlIl Boehringer
IGF-1 0.1-25 ngml-' Boehringer
IGF-2 10-200ngml-' Sigma
Insulin 0.5-25pgml-' Sigma
TGF-a 5-25Ongml-' Gibco
TGF-P 0.5-20mgml-' British Biotechnology
FGF I-lOOngmlP' Sigma
aFGF 0.5-50ngml-' Sigma
PGE2 InM-l tA Sigma
Bombesin 0.1-lOOngmln' Sigma
PDGF 0.05-10 nm Boehringer
IFN-a 10-500 ngml ScheringPlough
IFN-y 0-500ngml-' Sigma
KGF l-lOOngml-' BiotehTrade&Service
IL-la 10-500mPgm1 Genetics Institute
IL-2 0.1-lOOngml' Eurocetus
IL-6 5-25Q0ngml-' Boehringr
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(CM) of 0.25 gim DX. and compared with serum-free medium
alone (SF) and 0.25 !LM DX in serum-free medium (DX).
Some samples were exposed to medium conditioned without
DX but with 0.25 JM DX added during exposure to the A549
cells (CM + DX). DX was stimulatory (Table II), but
DXCM and CM + DX gave greater stimulation than DX
alone, indicating a synergistic interaction with CM. which
was inactive alone.
Specificitv offibroblasts
When medium was conditioned by a number of different
types of fibroblast. in the presence and absence of DX,
induction of alkaline phosphatase was seen with all of them.
but, while DXCM was generally more active than CM + DX
with LFl 13 (lung fibroblasts) and 9E (3T3 subline) cells.
breast and skin fibroblasts gave less active DXCM (Figure
2).
Effect ofknown grow*thfactors and c)tokines
Sixteen different growth factors were examined alone and in
combination with DX. Their effects can be divided into three
groups: (1) stimulatory - IFN-a, IL-6, insulin and bFGF
(Figure 3); (2) inhibitory - TGF-P, TGF-a, EGF and IL-1
(Figure 4); and (3) no or minimal effect - insulin-like growth
factor I (IGF-I), IGF-2, keratinocyte growth factor (KGF),
IFN-y, prostaglandin E2, aFGF (FGF-1), bombesin and
PDGF. Stimulation by all except bFGF required the
presence of DX and, in some cases, inhibition in the absence
of DX was abolished by the presence of DX.
Induction of AP was observed, in the presence of 0.25 jAM
DX, throughout the range of concentrations of IFN-a used,
reaching 60% relative to the DX control at 500 ngml-'
(Figure 3a). Thirty per cent induction was observed in the
absence of DX. Maximum induction, 2.5-fold, with IL-6 was
obtained at 25Aggml m' in the presence of DX, and about
40% induction in the absence of DX (Figure 3b). Insulin
gave maximum induction, 2.4-fold, at 1.0fg ml'i in the
presence of DX with little or no stimulation without DX
(Figure 3c). Basic FGF gave about 70% stimulation in the
Table H Induction ofalkaline phosphatase by fibroblast-conditioned
medium in the presence and absence of dexamethasone
p.mol PNP x 10-s cells ± s.e.m.
No DX 0.255 Mw DX
Serum free medium 16.05±0.69 37.48±0.85
Fibroblast-conditioned medium 15.46± 1.45 60.22±4.08
Medium conditioned in the 79.03± 3.52
presence of DX
c;
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Fiwe 2 Specificity of fibroblasts used in conditioning. Condi-
tioned medium was prepared from four different types of fibro-
blast, in the presence ( M ) or absence (-) of 0.25 JIM DX and
added to cultures of A549 cells alone (- or E ) or with added
0.25 9LM DX ( M ). CTRL, serum free medium control; LF. lung
fibroblast-conditioned medium; BF, breast fibroblast-conditioned
medium; 9E, medium conditioned by derivative of 3T3 cells
(D Wynford-Thomas, personal communication); SF. skin fibro-
blast (courtesy of Professor K Whaley).
absence of DX. peaking at 1.0 ng ml-'. and only about 500
in its presence (Figure 3d).
TGF-13. in the absence of DX. reduced AP activity bv
about 40% at 20ngml-l (P<0.05). In the presence of
0.25 gtm DX it was inhibitory above 2.0 ngml-' down to
about 30% of the DX-induced actiVity at 20 ngml-' (Figure
4a). The increase at 0.5 ng ml-. in the presence of DX. is
probably not significant and. more likely. represents an
antagonistic effect of DX on the TGF-P inhibition. TGF-e
was inhibitory in the absence of DX. giving 33% inhibition
at 20 ng ml-' (P<0.005) (Figure 4b). Apparent stimulation
by 100 ng ml-' in the presence of DX is not significant
(P>0.1). EGF was inhibitory. reaching 500o by 50 ng ml-'
(P<0.001) (Figure 4d). EGF showed 30% induction (P<
0.001) in 0.25 gM DX and. while this was evident at only one
point. 1.0 ng ml- '. similar induction was also observed in
1.0-10ngml-' EGF in a similar experiment using 10 M
DX (data not shown). IL-lx was antagonistic to the effect of
DX at the lowest concentration used. 10 Lg ml-' (P<0.001)
and above that had little additional effect. It gave a 40%
reduction in AP activity in the absence of DX (P<0.001)
(Figure 4c).
The remaining growth factors had very little effect. Prosta-
glandin En gave about 3000 stimulation in the presence of
DX and about 30% inhibition in its absence (data not
shown).
Combinations ofgrow thfactors
Combinations of IFN-m. IL-6 and insulin were additive, and.
together. in the presence of 0.25 ;M DX. gave greater induc-
tion than CM + DX and similar to DXCM. The effect of the
combined growth factors is visible without DX. but DX still
increases their effect about 4-fold.
The effect of the growth factors IFN-m. IL-6 and insulin
combined at their optimal concentrations was determined in
the presence of different concentrations of DX from 50 nM to
10 jiM. An increasing effect is seen with higher DX concen-
trations, but the relative effect of the combined growth fac-
tors over DX alone remains the same. Insulin also has a
similar inductive effect regardless of the DX concentration.
but IL-6 requires a minimum of 0.25 gM DX and IFN-a
shows the greatest effect at 10 jiM DX.
Reversibiliti
A549 cells were exposed to DX. DXCM and CM + DX and
then returned to 1% serum-supplemented medium. When
DXCM or CM + DX was removed. AP activitv declined
reaching about 50% by 7 days (Figure 6). Cells exposed to
IFN-a. IL-6 and insulin, alone or combined, also showed
reversal of alkaline phosphatase induction with a similar
half-life. These experiments were conducted at a relatively
high cell density and in 1% serum, added after the induction
period. While cell proliferation did occur. it had increased by
only 36% by 7 days after removal of DXCM. considerably
less than the doubling that would be necessary to dilute out
the effect of the induction. On removal of the combined
growth factors and DX. cell number was higher at the time
of removal and had only increased by <2% by 7 days (Table
III).
IL-6 bioassay
IL-6 has been shown to be a specific mitogen for B9
myeloma cells. so stimulation of myeloma proliferation
(Wadhwa et al., 1991) was used to assay IL-6 in CM and
DXCM. CM contained significant amounts of IL-6 (Table
IV). but this was reduced 10-fold in DXCM.
Plasminogen activator
Plasminogen activator activity was measured in microtitra-
tion plate cultures, following exposure to 1.0 jg ml-' insulin.
2.5;jg ml-' IL-6 and 500 ng ml-' IFN-a, individually. com-
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Figue 3 Effect of positive-acting growth factors on alkaline phosphatase induction in A549 cells. Cultures of A549 cells were
exposed to a range of concentrations of growth factors for 3 days in the absence of DX (0) or in the presence of 0.25 iLM DX (0)
and then assayed for alkaline phosphatase activity. a, IFN-o; b, IL-6; c, insulin; and i, bFGF.
bined and with and without 0.25 gM DX. DX inhibited PA
activity in all combinations, while all three growth factors
increased PA activity, IL-6 giving the greatest increase (Table
V). The combined effects of the growth factors were not
additive, and all three factors together showed only slightly
greater activity than the control. The reduction of PA by DX
was antagonised by IL-6 and, to a lesser degree, by IFN-x
and insulin; the combination of all three factors completely
blocked the inhibition produced by DX.
Discusso
Alkaline phosphatase activity has been described as a marker
for maturation of the type II pneumocyte and is not express-
ed in other alveolar cells (Edelson et al., 1988). The A549 cell
line was derived from a type II pneumocyte tumour (Giard et
al., 1972) and is still capable of expressing some type II
properties, such as production of pulmonary surfactant (PS)
(Lieber et al., 1976). Previous results from this laboratory
have shown that A549 cells can be induced to differentiate by
a paracrine factor, or factors, released from human fetal lung
fibroblasts under the control of dexamethasone (Speirs et al.,
1991). This may be analogous to the paracrine control of
perinatal alveolar type II cell maturation by
fibrocyte-pneumocyte factor (FPF) described by Post et al.
(1984). The present study was undertaken to determine
whether alkaline phosphatase (AP) responds to medium con-
ditioned by DX-treated fibroblasts, and would thereby pro-
vide a simpler assay for screening potentially active growth
factors, including those purified from conditioned medium.
The data show that AP was induced by fibroblast-
conditioned medium but, unlike the stimulation of PS,
required the continued presence of DX. Even medium condi-
tioned in the absence of DX could be shown to be active if
DX was supplied during induction. This appears to differ
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Figue 4 Effect of growth factors which repressed alkaline phosphatase activity. Conditons as for Figure 3. a, TGF-P; b, TGF-x. c,
IL-1m; and d, EGF.
from the PS-inducing activity of conditioned medium from
DX-treated fibroblasts (DXCM), where induction was main-
tained after removing DX, and in a semipurified extract
(FDF) obtained from DXCM. We are now undertaking
purification studies to determine whether the activity in
fibroblast-conditioned medium responsible for AP induction
is the same as that which induced PS in previous studies.
A number of growth factors have been shown to be active
in the AP assay, namely IFN-a, IL-6 and insulin. IL-6 has
been shown to be a paracrine factor in uterus (Jacobs et al.,
1992), and IFN-x has been associated with differentiation in
a number of systems (Kohlhepp et al., 1987; Pfeffer and
Eisenkraft, 1991). In the present series of expenrments activity
was dependent on DX when the growth factors were used
individually. Although significant activity was demonstrable
in growth factor combinations without DX, DX still more
than doubled the response.
IL-6 was shown to be present in CM but reduced in
DXCM, making it unlikely that IL-6 is the major activity in
DXCM, although it may be responsible for much of the
activity in CM + DX. IFN-z was also shown to be active,
though not as active as IL-6, and dependent on DX. The
other major active factor was insulin. While both IFN and
IL-6 are reasonable candidates for paracrine factors released
by fibroblasts, this is not a likely role for insulin. Insulin has
been shown to be active in the induction of differentiation of
breast secretory epithelium (Stockdale and Topper, 1966;
Gaben-Gogneville et al., 1990; Takabashi et al., 1991) and it
may have a general systemic role. IGF-I and IGF-II have
been shown to act as paracrine factors (Quinn et al., 1990;
Eicher et al., 1993) and to be released from fibroblasts.
However, neither of these factors demonstrated any
significant activity in the present system, although IGF-I
gave 75% stimulation in the PS assay (Speirs et al., 1991).
Use of antibody to the IGF-I receptor did not block induc-
tion by insulin (data not shown). No attempt was made to
assay for IGF-binding proteins; these could have been
released from either the A549 cells or the fibroblasts and
could have altered the response to exogenous IGF.
EGF and TGF-x were inhibitory in the absence of DX,
with EGF being the more potent. DX was able to reverse the
inhibitory effect of both of these factors. TGF-P was also
inhibitory, as previously reported (Torday and Kourem-
banas, 1990), and this was only reversed by DX at low
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Fig_e 6 Reversibility of induction of alkaline phosphatase
activity by conditioned medium and growth factors. Induction
was carried out as previously (see Materials and methods and
Figure 3) and alkaline phosphatase activity was measured before
induction (day -3), immediately after induction for 3 days (day
0) and at intervals after removal of inducers. 0, Serum-free
control; U, 0.25 gM DX; 0, conditioned medium with 0.25 jM
DX; A, medium conditioned by 0.25pm DX-treated fibroblasts;
O, conditioned medium alone; 0, IFN-4 + IL-6 + INS.
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Fue 5 Effect of combined growth factors on alkaline phos-
phatase activity. A549 cells were treated as described in the
Materials and methods section with each growth factor individ-
ually or in dual or triple combinations. a, Induction with 0.25 iM
DX (0), *, No DX. SF, serum-free control; CM, fibroblast-
conditioned medium; DXCM, medium conditioned by fibroblasts
in the presence of 0.25 .uM DX; IFN, 20ngml-' interferon a;
IL-6. 2.5 gml
' interleukin 6; INS, 2.5 jugml- insulin b, Effect
at different DX concentrations (M). 0- --0, SF; ---,
IFN + INS + IL-6; OO., IFN; @0 , IL-6; A -A, INS.
concentrations of TGF-P. As well as facilitating the stimula-
tion of positively acting factors, DX may be able to
antagonise inhibition by negatively acting factors. In the case
of IL-la, however, the degree of inhibition was greater in the
presence of DX.
Basic FGF (FGF-2) gave 75% induction of AP in the
absence of DX, and this was not increased by DX. Basic
FGF also stimulates PS synthesis by 83% (Speirs et al.,
1991). This suggests that bFGF might have a role in condi-
tioned medium, but, as it is not DX-dependent, it is not the
major activity in the induction of AP. Its activity was also
much less than FDF in the induction of PS synthesis (Speirs
et al., 1991), so, although it may be contributory, it is not
likely to be the sole factor. Many growth factors of the FGF
family have been shown to be dependent on heparin sulphate
proteoglycan (HSPG) for activity (Klagsbrun and Baird,
1991). It is possible that HSPG was present as a contaminant
in FDF prepared by Speirs et al. (1991), as the factor was
not purified to homogeneity, and that this promoted the
higher activity of FDF. The role of bFGF may therefore be
more significant in PS synthesis than in AP induction.
Preliminary experiments suggest that exogenous heparin has
no effect on induction of AP by DXCM or CM + DX (C
McCormick and RI Freshney, unpublished observations).
TableIII Cell numberperwellfollowing removal ofinducers (mean of
duplicate counts)
Days after removal
ofDXCM or growth Combinedgrowth
factors DXCM CM + DX factors
0 1.30 x1I 1.10 x I 1.01 x 10
1 1.25 x 105 1.08 x 10 1.08 x1I
4 1.22 x 105 1.10 x I 1.25 x I0
7 1.32 x105 1.21 x105 1.37 x 105
10 1.46 x I 1.50 x I 1.49 x 105
15 1.69 x 10 1.71 x I02 1.88 x 105
Table IV Concentration of IL-6 in conditioned medium
IL-6
Code Condition (pg ml')
SF Sham incubated control medium 0
CM Medium conditioned without DX 180.2
CM + DX Medium conditioned without DX 125.0
and 0.25tM DX added before
assay
DXCM Medium conditioned in the presence 10.5
of 0.25 pm DX
CM+DX+ CM + DX with 1:I00 NIBBSC IL-6 16.2
NIBSC antibody antibody
Table V Effect of growth factors on plasminogen activator activity
Ploug units x 10-6 cells
No DX 0.25ILM DX
Growthfactor Mean s.e. Mean s.e.
SF 0.888 0.088 0.299 0.04
IFN-a 1.055 0.024 0.374 0.031
Insulin 1.00 0.015 0.431 0.043
IL-6 1.319 0.048 0.802 0.018
IFN-a+Insulin 1.201 0.063 0.398 0.074
IFN-a+IL-6 1.435 0.027 0.660 0.093
Insulin + IL-6 1.468 0.890 0.079
IFN-a+insulin + IL-6 1.072 0.046 0.945 0.103
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If both PS and AP are products of the differentiated type
II cell phenotype. it would be natural to expect their induc-
tion to be coordinated. The activity of fibroblast-conditioned
medium in both systems suggests that this may be the case.
but there are sufficient differences. e.g. DX dependence, to
suggest that the induction mechanisms may not be identical.
A stricter comparison of PS and AP induction by fractions
purified from DXCM is therefore required.
AP induction activity was seen in conditioned media from
several different fibroblasts, but while DX treatment
enhanced lung fibroblast and 9E cell conditioning of the
medium, it inhibited the production of inducing activity by
skin and breast fibroblasts. Alternatively, DX may have
induced an inhibitor, such as TGF-P (Torday and Kourem-
banas, 1990). in skin and breast fibroblasts. As several para-
crine factors have activity in this system. it is not surprising
to find AP-inducing activity in conditioned medium from
different fibroblasts. However, the net activity of the condi-
tioned medium is probably the product of interaction
between a number of active inducers and inhibitors. This
balance is likely to vary among fibroblasts used for condi-
tioning, and may well be regulated differently by systemic
factors such as hydrocortisone and by proximity to specific
types of epithelium. The resolution of this problem will
require more detailed analysis of positive- and negative-
acting paracrine factors in conditioned medium from
different sources.
The role of DX in this system is still not entirely clear. It
may induce an alteration in the matrix products of either the
fibroblasts or the A549 cells. Mackie et al. (1988) showed
that glucocorticoids could promote a shift from free hyalu-
ronic acid to cell-associated sulphated proteoglycans, partic-
ularly heparan sulphate, in human glioma cultures. Such an
alteration in the present system could have a profound effect
on growth factor activity, stability and receptor binding
(Casillas et al., 1991; Klagsbrun and Baird, 1991; Rusnati et
al., 1993). Preliminary studies with DX treatment of A549
(J Robertson and RI Freshney, unpublished observations)
suggest that the effect of DX on promoting DXCM activity
is relatively stable and is still present 3 days after DX
removal. This would be compatible with matrix alteration.
rather than an effect on signal transduction. which might be
expected to be more transitory.
It is also possible that DX may affect the receptor status of
the A549 cells. Up-regulation of the receptors for each of the
effective factors is likely to enhance their effect, but, again, a
half-life of 7 days would not be expected for receptor turn-
over, which is more likely to be in the region of a few hours.
The receptor status of the A549 cells has not been deter-
mined but is clearly worthy of investigation as it may explain
some of the differences in responsiveness to different fac-
tors.
Withdrawal of DXCM after induction of AP showed that
the AP activity of the A549 cells decayed over a period of
more than 1 week, suggesting that the phenotypic change is
reversible, but with a relatively slow reversion rate. While the
cell number increased with continued culture after removal of
inducers. the amount of cell replication was not sufficient to
account for the loss of activity, unless differentiated cells
were actively lost from the population, e.g. by apoptosis.
while undifferentiated cells proliferated. There was no
obvious sign of this (increase in floating dead cells) but it will
require more detailed analysis.
So far, the identity of the active factor(s) in fibroblast-
conditioned medium remains unknown, but IL-6 and IFN-z
are possible candidates. However, IL-6 and IFN-m, alone and
in combination, stimulate plasminogen activator, while pre-
vious results with FDF showed that it is inhibitory. Pre-
liminary attempts at purification (Speirs et al.. 1991;
C McCormick, L Evans and RI Freshney. unpublished ob-
servations) demonstrated that it is acid labile. protease sen-
sitive and binds to cation ion exchange. Further purification
and characterisation of active fractions from conditioned
medium is currently under way.
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